Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 17/11/2009
PIL Hypovase Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 02/09/2009 and displayed until 17/11/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 22/05/2008 and displayed until 02/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 30/08/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 28/06/2007 and displayed until 30/08/2007
Reasons for adding or updating:
  • PIL Product / presentation discontinued
  • Change to appearance of the medicine
  • Change to packaging
  • Change of manufacturer
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 22/03/2006 and displayed until 28/06/2007
Reasons for adding or updating:
  • Change to packaging
  • Change to side-effects
  • Change to date of revision
Updated on 26/01/2005 and displayed until 22/03/2006
Reasons for adding or updating:
  • Change of contra-indications
Updated on 13/09/2000 and displayed until 26/01/2005
Reasons for adding or updating:
  • No reasons supplied
Updated on 08/08/2000 and displayed until 13/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   prazosin hydrochloride